Peer Review reports
From: Repurposing existing drugs for COVID-19: an endocrinology perspective
Original Submission | ||
---|---|---|
16 Jun 2020 | Submitted | Original manuscript |
3 Jul 2020 | Reviewed | Reviewer Report |
17 Jul 2020 | Reviewed | Reviewer Report |
27 Jul 2020 | Author responded | Author comments - Flavio Cadegiani |
Resubmission - Version 2 | ||
27 Jul 2020 | Submitted | Manuscript version 2 |
26 Aug 2020 | Author responded | Author comments - Flavio Cadegiani |
Resubmission - Version 3 | ||
26 Aug 2020 | Submitted | Manuscript version 3 |
8 Sep 2020 | Author responded | Author comments - Flavio Cadegiani |
Resubmission - Version 4 | ||
8 Sep 2020 | Submitted | Manuscript version 4 |
Publishing | ||
14 Sep 2020 | Editorially accepted | |
29 Sep 2020 | Article published | 10.1186/s12902-020-00626-0 |
You can find further information about peer review here.